Exclusive

Publication

Byline

Location

US Patent Issued to The Johns Hopkins University on Oct. 27 for "MANAbodies and methods of using" (Maryland, Washington, Delaware Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,336, issued on Oct. 27, was assigned to The Johns Hopkins University (Baltimore). "MANAbodies and methods of using" was invented by Emily H... Read More


US Patent Issued to DIZAL PHARMACEUTICAL on Oct. 27 for "Anti-FGFR2b antibodies" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,337, issued on Oct. 27, was assigned to DIZAL PHARMACEUTICAL Co. LTD. (Wuxi, China). "Anti-FGFR2b antibodies" was invented by Mei Wang (Sha... Read More


US Patent Issued to Astellas Pharma on Oct. 27 for "Multispecific antibody binding to ActRIIA, ActRIIB, and Fn14" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,338, issued on Oct. 27, was assigned to Astellas Pharma Inc. (Tokyo). "Multispecific antibody binding to ActRIIA, ActRIIB, and Fn14" was in... Read More


US Patent Issued to ETABLISSEMENT FRANCAIS DU SANG, INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON, UNIVERSITE DE FRANCHE-COMTE on Oct. 27 for "CAR-T cells targeting IL-1RAP and their use in acute myeloid leukemia (AML)" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,339, issued on Oct. 27, was assigned to ETABLISSEMENT FRANCAIS DU SANG (La Plaine Saint-Denis Cedex, France), INSTITUT NATIONAL DE LA SANTA ... Read More


US Patent Issued to BIOTHEUS on Oct. 27 for "Anti-4-1BB single-domain antibodies, nanobodies, fusion proteins thereof and methods of use thereof for treatment" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,340, issued on Oct. 27, was assigned to BIOTHEUS INC. (Zhuhai, China). "Anti-4-1BB single-domain antibodies, nanobodies, fusion proteins th... Read More


US Patent Issued to BIOSION on Oct. 27 for "Antibodies binding BCMA and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,341, issued on Oct. 27, was assigned to BIOSION INC. (Nanjing, China). "Antibodies binding BCMA and uses thereof" was invented by Mingjiu C... Read More


US Patent Issued to Regeneron Pharmaceuticals on Oct. 27 for "Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,342, issued on Oct. 27, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Methods of treating multiple myeloma with bispec... Read More


US Patent Issued to ACTINIUM PHARMACEUTICALS on Oct. 27 for "Humanized anti-CD45 antibodies" (New York, California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,343, issued on Oct. 27, was assigned to ACTINIUM PHARMACEUTICALS INC. (New York). "Humanized anti-CD45 antibodies" was invented by Lequn Zh... Read More


US Patent Issued to Akeso Biopharma on Oct. 27 for "Anti-CD73 antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,344, issued on Oct. 27, was assigned to Akeso Biopharma Inc. (Zhongshan, China). "Anti-CD73 antibody and use thereof" was invented by Zhong... Read More


US Patent Issued to CHUGAI SEIYAKU on Oct. 27 for "Immunoactivating antigen-binding molecule" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,345, issued on Oct. 27, was assigned to CHUGAI SEIYAKU K.K. (Tokyo). "Immunoactivating antigen-binding molecule" was invented by Tomoyuki I... Read More